PEDIATRICS Vol. 90 No. 1 July 1992, pp. 170-173
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stevens, C. E.
Right arrow Articles by Yip, H.-Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stevens, C. E.
Right arrow Articles by Yip, H.-Y.

Prospects for Control of Hepatitis B Virus Infection: Implications of Childhood Vaccination and Long-term Protection

Cladd E. Stevens MD1, Pearl T. Toy MD1, Patricia E. Taylor PhD1, Thomas Lee 1, and Hoo-Yi Yip 1

1 From the Wolf Szmuness Laboratory of Epidemiology, The New York Blood Center, New York, NY

Hepatitis B vaccine has been recommended for high-risk individuals in the United States for more than a decade. This targeted strategy, however, has failed to control hepatitis B virus (HBV) infection. Universal immunization is being considered as an alternative approach, in particular the inclusion of hepatitis B vaccine with routine childhood vaccinations. Data presented herein demonstrate a high degree of efficacy for hepatitis vaccine with hepatitis B immune globulin in preventing perinatal HBV infection in newborns. Immune response to vaccine was dependent in part on the dose administered, with some enhancement of response if the infant was older at the time of initial injection or if the booster dose was given later. Long-term follow-up showed persistence of vaccine-induced antibody for 5 to 10 years in 90% of immunized infants and adults. Only 3% to 5% of these high-risk individuals had serologic evidence of an HBV infection. None of the infections had been symptomatic and none resulted in a chronic HBV carrier state. Thus, immune responses and efficacy of hepatitis B vaccine in infants were excellent, and immunity and protection against clinically significant HBV infection persisted for at least 5 to 10 years, features essential to success of a program of universal childhood immunization against HBV

Key Words: hepatitis B virus • vaccination • immunization

Submitted on January 21, 1992
Accepted on March 10, 1992




This article has been cited by other articles:


Home page
 ANN INTERN MEDHome page
B. J. McMahon, D. L. Bruden, K. M. Petersen, L. R. Bulkow, A. J. Parkinson, O. Nainan, M. Khristova, C. Zanis, H. Peters, and H. S. Margolis
Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-up
Ann Intern Med, March 1, 2005; 142(5): 333 - 341.
[Abstract] [Full Text] [PDF]

Home page
 JBJSHome page
K. C. Wong and K. S. Leung
Transmission and Prevention of Occupational Infections in Orthopaedic Surgeons
J. Bone Joint Surg. Am., May 1, 2004; 86(5): 1065 - 1076.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
N. A. Halsey
Limiting Infant Exposure to Thimerosal in Vaccines and Other Sources of Mercury
JAMA, November 10, 1999; 282(18): 1763 - 1766.
[Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
F. J. Mahoney
Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection
Clin. Microbiol. Rev., April 1, 1999; 12(2): 351 - 366.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
F.-Y. Huang, P.-I. Lee, C.-Y. Lee, L.-M. Huang, L.-Y. Chang, and S.-C. Liu
Hepatitis B vaccination in preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 1997; 77(2): 135F - 138.
[Abstract] [Full Text]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
Y. Poovorawan, S. Sanpavat, S. Chumdermpadetsuk, and A. Safary
Long term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 1997; 77(1): 47F - 51.
[Abstract] [Full Text]

Home page
 NEJMHome page
R. J. Kim-Farley, M. H. Merson, J. L. Tulloch, F. Deisenhammer, P. Pohl, G. Grubwieser, S. Sepkowitz, and G. Peter
Childhood Immunizations
N. Engl. J. Med., May 13, 1993; 328(19): 1420 - 1422.
[Full Text]